We’ve all heard of Ozempic by now. It’s only licensed for use as a diabetes treatment in the UK and US, but it's widely used ‘off label’ to help people lose weight. So much so, in fact, that its name ...
Those taking GLP-1s had small but significant reductions in their 10-year chances of vertebral fractures, suggesting that the ...
Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...
It’s a tough pill to swallow. There are countless supplements and pantry staples out there that swear to help people slim down, from apple cider vinegar shots to “nature’s Ozempic”. But one popular ...
In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 medication for ...
Everyday Health on MSN
How weight loss pills have changed — and what that means for safety
Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Learn more about today’s better-regulated drugs on the market.
Brands are claiming their products will help to burn fat, block carbs or suppress your appetite. Or, that their products can increase GLP-1 production (the appetite-regulating hormone that ...
Wegovy pills are now available in the U.S., offering a prescription-based, convenient alternative for weight management ...
More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.
Analysts say GLP-1 weight-loss drugs could make airfare cheaper by reducing fuel costs as passengers get thinner. Experts ...
The Independent on MSN
Supermarket targets weight loss jab users with new high protein meals
UK supermarket giant targets weight loss jab users with new ‘nutrient-rich’ protein meals - Each meal in its ‘small but ...
The growing use of weight-loss products may end up saving the biggest U.S. airlines as much as $580 million in fuel costs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results